Impaired induction of the CD28-responsive complex in granulocyte colony- stimulating factor mobilized CD4 T cells

Blood

Volumn 91, Issue 1, 1998, Pages 347-352

  Tanaka, Junji ^a   Mielcarek, Marco ^b   Torok Storb, Beverly ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANULOCYTE COLONY STIMULATING FACTOR; OKT 3;

ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0031964655     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.347     Document Type: Article

References (38)

1. Tanaka J, Kasai M, Imamura M, Higa T, Zhu X, Kobayashi S, Imai R, Hashino S, Sakurada K: Potential benefit of rhG-CSF mobilized peripheral blood stem cells for allogeneic transplantation (letter). Blood 84:3595, 1994
2. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
3. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma-potential advantage of blood over marrow allografts. Blood 85:1659, 1995
4. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (G-CSF). Blood 85:1666, 1995
5. Tanaka J, Kasai M, Imamura M, Asaka M: Clinical application of allogeneic peripheral blood stem cells transplantation. Ann Hematol 71:265, 1995
6. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88:4132, 1996
7. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997
8. Pan L, Delmonte J, Jr, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft versus host disease. Blood 86:4422, 1995
9. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89:1629, 1997
10. + cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87:574, 1996
11. Mielcarek M, Purton LE, Torok-Storb B: Accessory function may be retained in CD34-selected G-CSF-mobilized peripheral blood mononuclear cells (letter). Br J Haematol 93:491, 1996
12. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VAJ, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909, 1993
13. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721, 1991
14. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 88:6575, 1991
15. Go C, Miller J: Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J Exp Med 175:1327, 1992
16. Umlauf SW, Beverly B, Kang S-M, Brorson K, Tran A-C, Schwartz RH: Molecular regulation of the IL-2 gene: Rheostatic control of the immune system. Immunol Rev 133:177, 1993
17. Fraser JD, Irving BA, Crabtree GR, Weiss A: Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313, 1991
18. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607, 1992
19. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS: Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177:165, 1993
20. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90:6586, 1993
21. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM: B7 but not intercellular adhesion molecule 1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 178: 1753, 1993
22. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet graft induced by CTLA4Ig. Science 257:789, 1992
23. Blazar BR, Taylor PA, Linsley PS, Vallera DA: In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA-4 Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 83:3815, 1994
24. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA: Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 85:2607, 1995
25. Ghosh P, Tan T-H, Rice NR, Sica A, Young HA: The interleukin 2 CD28-responsive complex contains at least three members of the NF KB family: c-Rel, p50, and p65. Proc Natl Acad Sci USA 90:1696, 1993
26. Bryan RG, Li Y, Lai JH, Van M, Rice NR, Rich RR, Tan TH: Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol Cell Biol 14:7933, 1994
27. Robinet E, Fournel S, Fatmi A, Revillard JP: IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering. Cell Immunol 167:1, 1996
28. Becker JC, Brabletz T, Kirchner T, Conrad CT, Broecker E-B, Reisfeld RA: Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci USA 92:2375, 1995
29. Schreiber E, Matthias P, Mueller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
30. Gribben JG, Guinan EC, Boussiotis VA, Ke XY, Linsley L, Sieff C, Gray GS, Freeman GJ, Nadler LM: Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool. Blood 87:4887, 1996
31. Thomas R, Davis LS, Lipsky PE: Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 151:6840, 1993
32. Egner W, Andreesen R, Hart DN: Allostimulatory cells in fresh human blood: Heterogeneity in antigen-presenting cell populations. Transplantation 56:945, 1993
33. Laughter AH, Twomey JJ: Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes. J Immunol 119:173, 1977
34. Goto S, Kamada N, Kim YI, Kobayashi M: Induction of immunosuppressive activity by splenic macrophages in liver-grafted rats. Transplant Proc 23:2017, 1991
35. Okragly AJ, Hanby-Flarida M, Baldwin CL: Monocytes control γ/δ T-cell response by a secreted product. Immunol 86:599, 1995
36. Munn DH, Pressey J, Beall AC, Hudes R, Alderson MR: Selective activation-induced apoptosis of peripheral T cells imposed by macrophages - A potential mechanism of antigen-specific peripheral lymphocyte deletion. J Immunol 156:523, 1996
37. Romano MF, Lamberti A, Petrella A, Bisogni R, Tasone PF, Formisano S, Venuta S, Turco MC: IL-10 inhibits nuclear factor-κB/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol 156:2119, 1996
38. Paliogianni F, Boumpas DT: Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the IL-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. Cell Immunol 171:95, 1996